ASN
CCCC icon

Advisory Services Network’s C4 Therapeutics CCCC Stock Holding History

Advisory Services Network’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195 Buy
+74
New +$174 ﹤0.01% 4566
2025
Q4 		– Sell
-74
Closed -$164 – 2195
2025
Q3 		$164 Buy
+74
New +$178 ﹤0.01% 4254

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Advisory Services Network's CCCC Position: Q1 2026 in Review

Advisory Services Network opened a new position in C4 Therapeutics (CCCC) in Q1 2026: 74 shares worth $195. The stake represents ﹤0.01% of the portfolio and ranks #4566 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CCCC as recently as Q3 2025.

Advisory Services Network first reported a position in CCCC in Q3 2025 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Advisory Services Network held 74 shares of C4 Therapeutics worth $195 as of Q1 2026.
  • C4 Therapeutics was a new Advisory Services Network position in Q1 2026.
  • C4 Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4566 holding.
  • Advisory Services Network first reported a position in C4 Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.